| Title |
Azithromycin versus penicillin G benzathine for early syphilis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2012
|
| DOI | 10.1002/14651858.cd007270.pub2 |
| Pubmed ID | |
| Authors |
Zheng Gang Bai, Baoxi Wang, KeHu Yang, Jin Hui Tian, Bin Ma, Yali Liu, Lei Jiang, Qiong Yan Gai, Xiaodong He, Youping Li |
| Abstract |
Syphilis is a complex systemic disease caused by a spirochete, Treponema pallidum. The World Health Organization estimates that at least 12 million people worldwide are currently infected with syphilis. In this review we compared two current standards of treatment for early syphilis, benzathine benzylpenicillin (penicillin G) and azithromycin. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 2% |
| South Africa | 1 | <1% |
| Unknown | 105 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 18 | 17% |
| Researcher | 12 | 11% |
| Student > Bachelor | 9 | 8% |
| Other | 9 | 8% |
| Student > Doctoral Student | 6 | 6% |
| Other | 17 | 16% |
| Unknown | 37 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 33 | 31% |
| Nursing and Health Professions | 14 | 13% |
| Social Sciences | 4 | 4% |
| Agricultural and Biological Sciences | 4 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Other | 10 | 9% |
| Unknown | 40 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 56. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2023.
All research outputs
#757,319
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#1,413
of 11,499 outputs
Outputs of similar age
#3,782
of 181,239 outputs
Outputs of similar age from Cochrane database of systematic reviews
#17
of 175 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 181,239 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 175 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.